Valuation : DongKook Pharmaceutical Co., Ltd.

Market Cap 890B 665M 572M 538M 491M 918M 63.23B 922M 6.38B 2.47B 32.21B 2.5B 2.44B 102B P/E 2026 *
10.5x
P/E 2027 * 9.06x
Enterprise Value 844M 630K 542K 511K 465K 870K 59.96M 874K 6.05M 2.34M 30.55M 2.37M 2.31M 96.77M EV / Sales 2026 *
0.81x
EV / Sales 2027 * 0.71x
Free-Float
55.72%
Yield 2026 *
1.01%
Yield 2027 * 1.01%
08-13 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07-01 Faes Farma Enters Exclusive License, Supply Deal for Prostate Disease Treatment MT
05-14 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-22 S.Biomedics Co., Ltd. announced that it has received KRW 39.999778584 billion in funding from Hanwha Investment & Securities Co., Ltd., DongKook Pharmaceutical Co., Ltd. and other investors CI
04-13 S.Biomedics Co., Ltd. announced that it expects to receive KRW 39.999778584 billion in funding from Hanwha Investment & Securities Co., Ltd., DongKook Pharmaceutical Co., Ltd and other investors CI
03-12 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
12-11 DongKook Pharmaceutical Co., Ltd. announces Annual dividend, payable on April 18, 2026 CI
12-11 Dongkook Pharmaceutical to divest 7 billion won worth of own shares RE
11-14 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-14 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-11 Dongkook Pharmaceutical's Net Income Rises 16% in Q2 MT
25-08-11 Dongkook Pharmaceutical Q2 operating profit 22 billion won, up 15% from year earlier RE
25-05-14 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
1 day-0.95%
1 week-9.66%
Current month-11.28%
1 month+2.28%
3 months+11.34%
6 months+4.67%
Current year+15.10%
1 week 19,350
Extreme 19350
23,250
1 month 17,650
Extreme 17650
23,400
Current year 16,260
Extreme 16260
31,250
1 year 16,260
Extreme 16260
31,250
3 years 14,140
Extreme 14140
31,250
5 years 13,000
Extreme 13000
31,250
10 years 9,340
Extreme 9340
36,150
Manager TitleAgeSince
Chief Executive Officer 59 2022-03-24
Comptroller/Controller/Auditor 67 -
Corporate Officer/Principal 64 -
Director TitleAgeSince
Chairman 59 -
Director/Board Member 59 2022-03-24
Director/Board Member 83 2023-03-23
Date Insider Type Main position Quantity % Market Cap. Importance
4/11/24 Buy

Chief Executive Officer

6,000 0.0135%
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%-9.66%+11.65%+36.80% 665M
+0.03%-3.09%+49.77%+91.69% 1,002B
-0.76%-2.95%+50.93%+66.34% 644B
+0.86%-4.13%+19.24%+68.37% 443B
-0.80%-0.43%+28.92%+35.45% 343B
-0.13%-14.97%+9.41%+26.71% 262B
-1.90%-2.72%-2.72%+7.41% 245B
-0.48%-11.65%+39.75%+50.82% 212B
-1.06%-4.23%-14.70%-57.36% 199B
-0.68%-2.65%+25.82%+91.64% 181B
Average -0.60%-5.44%+21.81%+41.79% 353.03B
Weighted average by Cap. -0.42%-4.24%+32.03%+57.16%

Financials

2026 *2027 *
Net sales 1,044B 779M 670M 631M 575M 1.08B 74.1B 1.08B 7.48B 2.89B 37.75B 2.92B 2.86B 120B 1,178B 879M 757M 713M 649M 1.21B 83.68B 1.22B 8.45B 3.26B 42.63B 3.3B 3.23B 135B
Net income 84.9B 63.35M 54.52M 51.33M 46.77M 87.51M 6.03B 87.86M 608M 235M 3.07B 238M 233M 9.73B 98.6B 73.58M 63.31M 59.62M 54.32M 102M 7B 102M 707M 273M 3.57B 276M 270M 11.3B
Net Debt -46.1B -34.4M -29.6M -27.87M -25.4M -47.52M -3.27B -47.71M -330M -128M -1.67B -129M -126M -5.28B -53.3B -39.77M -34.23M -32.23M -29.36M -54.94M -3.78B -55.16M -382M -148M -1.93B -149M -146M -6.11B
Logo DongKook Pharmaceutical Co., Ltd.
Dongkook Pharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company is mainly engaged in the manufacture and sale of general medicines, prescription medicines, and active pharmaceutical ingredients (APIs). In addition, the Company supplies new drugs, improved drugs, and generic medicines. Furthermore, the Company manufactures and sells cosmetics, health functional foods, and household products. The Company mainly sells its products in domestic and overseas markets.
Employees
1,285
Date Price Change Volume
26-09-09 ₩19,740.00 -0.95% 381,188
26-09-08 ₩19,930.00 -4.18% 604,857
26-09-07 ₩20,800.00 -3.70% 400,549
26-09-04 ₩21,600.00 -0.92% 747,610
26-09-03 ₩21,800.00 -0.23% 962,970
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
19,740.00KRW
Average target price
30,000.00KRW
Spread / Average Target
+51.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A086450 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!